PETACH TIKVA, Israel, April 16, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical stage biotechnology company advancing its Molecular Nano Motor (MNM) intracellular delivery platform, today ...
Daiichi Sankyo has signed a research partnership with Interna Therapeutics to develop targeted delivery solutions based on molecular nano motor (MNM) technology. The agreement involves Daiichi Sankyo ...
PETACH TIKVAH, Israel, March 23, 2026 /PRNewswire/ -- Interna Therapeutics, a clinical-stage biopharmaceutical company announced today that it has signed an agreement with the University of Oxford to ...
UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, today announced the ...
UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today it received ...
— Adding deep preclinical and clinical immuno-oncology expertise to expand InteRNA’s preclinical pipeline and accelerate clinical-stage lead candidate INT-1B3 — UTRECHT, The Netherlands–(BUSINESS WIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results